North Korea’s admission that it is battling an “explosive” COVID-19 outbreak raised concerns that the virus could devastate a country with an under-resourced health system, limited testing capabilities, and no vaccine program.

Alabama reached $276 million in settlements with Johnson & Johnson, McKesson Corp. and Endo International Plc, resolving claims that the companies fueled an opioid addiction crisis, the state attorney general said.

With COVID-19 cases still high nationwide, “now is not the moment” to drop mask mandates in schools and other public places, U.S. Centers for Disease Control and Prevention (CDC) Director Dr. Rochelle Walensky told Reuters on February 8.

In order for healthcare organizations to create healthier communities, they need insight into more than clinical patient information. They also need to see behavioral health data, which is a major indicator of risk and trends for their population. Having access to this information can feed into more effective preventative and community-based mental health services and treatments for patients.

Ashfield Engage, part of UDG Healthcare plc, today announced that it has been selected by U.S.-based Pacira BioSciences Inc. to provide strategic commercialization services for the company’s non-opioid pain management products in select European countries. Pacira has partnered with Ashfield Engage to develop a commercial strategy and deliver outsourced operations in numerous European countries, including the UK, Germany, Sweden, Austria, the Netherlands and Finland.

New research from Klick Applied Sciences found that people using interactive voice technology for information on medications still get the most accurate results from Google Assistant. The data are especially relevant as consumers have increasingly been turning to these platforms during the pandemic.

India’s coronavirus crisis showed scant sign of easing on May 11, with a seven-day average of new cases at a record high and international health authorities warning the country’s variant of the virus poses a global concern.

President Joe Biden on May 5 threw his support behind waiving intellectual property rights for Covid-19 vaccines, bowing to mounting pressure from Democratic lawmakers and more than 100 other countries, but angering pharmaceutical companies. Biden voiced his support for a waiver – a sharp reversal of the previous U.S. position – in remarks to reporters, followed swiftly by a statement from his top trade negotiator, Katherine Tai, who backed negotiations at the World Trade Organization.

The U.S. Centers for Disease Control and Prevention on April 2 said fully vaccinated people can safely travel at “low risk” after the agency had held off for weeks on revising guidance that discouraged all non-essential trips.

U.S. President Joe Biden secured a commitment from Pfizer Inc. to double the Covid-19 vaccine the company churns out in the coming weeks, putting his goal to fill the country’s inoculation stockpile by summer in sight.